EUVIMEDEUVIMED entdecken
Crossref

Prognostic Significance of 18 F-FDG PET/CT and Tumor Metabolic Changes in Patients With Pancreatic Ductal Adenocarcinoma

Ayaka Shimomura, Minoru Oshima, Hironobu Suto, Hiroyuki Matsukawa, Akihiro Kondo, Yasuhisa Ando, Takayoshi Kishino, Kensuke Kumamoto, Kiyotoshi Sato, Masahiro Sugimoto, Mina Nagao, Nobuyuki Miyatake und 3 weitere

Anticancer Research · 2024

DOI: 10.21873/anticanres.17151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Ayaka Shimomura und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Kagawa University, Kagawa, Japan; shimomura.ayaka@kagawa-u.ac.jp. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Carcinoma, Pancreatic Ductal, Positron Emission Tomography Computed Tomography, Pancreatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) is reportedly associated with the malignant potential of cancer. This study aimed to evaluate the association between FDG accumulation and tumor metabolism in pancreatic ductal adenocarcinoma (PDAC). PATIENTS AND METHODS: A prognostic analysis of data from 131 patients with PDAC who underwent FDG-PET/CT before curative-intent pancreatic surgery was performed. Capillary electrophoresis-mass spectrometry (CE-MS) was used to analyze the metabolome of tumor and non-neoplastic pancreas from 80 patients. These patients were divided into two groups: low SUVmax group (SUVmax

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Carcinoma, Pancreatic DuctalPositron Emission Tomography Computed TomographyPancreatic NeoplasmsHumansMaleFemalePrognosisAgedMiddle AgedRadiopharmaceuticalsAdultAged, 80 and over

Stichwörter der Autor:innen

CE-MSFDG-PETMetabolomicsPDACSUVmax

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Gastroenterological Surgery, Kagawa University, Kagawa, Japan; shimomura.ayaka@kagawa-u.ac.jp.
  • Department of Gastroenterological Surgery, Kagawa University, Kagawa, Japan.
  • Institute for Advanced Biosciences, Keio University, Kakuganji, Tsuruoka, Japan.
  • Department of Hygiene, Kagawa University, Kagawa, Japan.
  • Department of Radiology, Kagawa University, Kagawa, Japan.

Zitieren

APA

Shimomura, A., Oshima, M., Suto, H., Matsukawa, H., Kondo, A., Ando, Y., Kishino, T., Kumamoto, K., Sato, K., Sugimoto, M., Nagao, M., Miyatake, N., Norikane, T., Soga, T., & Okano, K. (2024). Prognostic Significance of 18 F-FDG PET/CT and Tumor Metabolic Changes in Patients With Pancreatic Ductal Adenocarcinoma. Anticancer Research. https://doi.org/10.21873/anticanres.17151

Vancouver

Shimomura A, Oshima M, Suto H, Matsukawa H, Kondo A, Ando Y, et al. Prognostic Significance of 18 F-FDG PET/CT and Tumor Metabolic Changes in Patients With Pancreatic Ductal Adenocarcinoma. Anticancer Research. 2024. doi:10.21873/anticanres.17151

BibTeX
@article{Shimomura2024,
  author = {Shimomura, Ayaka and Oshima, Minoru and Suto, Hironobu and Matsukawa, Hiroyuki and Kondo, Akihiro and Ando, Yasuhisa and Kishino, Takayoshi and Kumamoto, Kensuke and Sato, Kiyotoshi and Sugimoto, Masahiro and Nagao, Mina and Miyatake, Nobuyuki and Norikane, Takashi and Soga, Tomoyoshi and Okano, Keiichi},
  title = {Prognostic Significance of 18 F-FDG PET/CT and Tumor Metabolic Changes in Patients With Pancreatic Ductal Adenocarcinoma},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17151}
}
Kostenlos starten →